prikaz prve stranice dokumenta Tumor immunotherapy side effects – early recognition and management
  Download
PDF 142.96 KB
Scientific paper - Review paper
Tumor immunotherapy side effects – early recognition and management
Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 78-80. urn:nbn:hr:184:134188
Pavlović Ružić, Ira; Zahirović, Dag; Pavlović, Sanja; Belac-Lovasić, Ingrid

Cite this document

Pavlović Ružić, I., Zahirović, D., Pavlović, S. & Belac Lovasić, I. (2017). Tumor immunotherapy side effects – early recognition and management. Libri Oncologici : Croatian Journal of Oncology, 45. (2-3), 78-80. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:134188

Pavlović Ružić, Ira, et al. "Tumor immunotherapy side effects – early recognition and management." Libri Oncologici : Croatian Journal of Oncology, vol. 45, no. 2-3, 2017, pp. 78-80. https://urn.nsk.hr/urn:nbn:hr:184:134188

Pavlović Ružić, Ira, Dag Zahirović, Sanja Pavlović and Ingrid Belac Lovasić. "Tumor immunotherapy side effects – early recognition and management." Libri Oncologici : Croatian Journal of Oncology 45, no. 2-3 (2017): 78-80. https://urn.nsk.hr/urn:nbn:hr:184:134188

Pavlović Ružić, I., et al. (2017) 'Tumor immunotherapy side effects – early recognition and management', Libri Oncologici : Croatian Journal of Oncology, 45(2-3), pp. 78-80. Available at: https://urn.nsk.hr/urn:nbn:hr:184:134188 (Accessed 25 November 2024)

Pavlović Ružić I, Zahirović D, Pavlović S, Belac Lovasić I. Tumor immunotherapy side effects – early recognition and management. Libri Oncologici : Croatian Journal of Oncology [Internet]. 2017 December 21 [cited 2024 November 25];45(2-3):78-80. Available at: https://urn.nsk.hr/urn:nbn:hr:184:134188

I. Pavlović Ružić, D. Zahirović, S. Pavlović and I. Belac Lovasić, "Tumor immunotherapy side effects – early recognition and management", Libri Oncologici : Croatian Journal of Oncology, vol. 45, no. 2-3, pp. 78-80, December 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:134188. [Accessed: 25 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Tumor immunotherapy side effects – early recognition and management
Title (croatian)Nepoželjne popratne pojave imunoterapije tumora
AuthorIra Pavlović Ružić
AuthorDag Zahirović
AuthorSanja Pavlović
AuthorIngrid Belac-Lovasić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Oncology and Radiotherapy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Oncology
Abstract (english)
Implementation of immunotherapy in many cancer types has achieved positive results in tumor control and cure. The concept of immunotherapy is diff erent in comparison with conventional tumor therapies. While chemotherapy, hormonal or biological therapies target tumor cells and mechanisms, immunotherapy targets host immune system. Amplifi cation of defending possibilities or unblocking the control of the immune reactions are used. Besides positive results in tumor control, enhancing immunogenicity can provoke harm to other tissues and systems in form of adverse reactions or unwanted side effects of therapy. Early recognition of side effects is of crucial importance and prompt care can diminish the harm and severity. Knowledge about side effects is needed, therefore good education of all medical personnel included in treatment as well as patient education must be assured prior and thorough the treatment. Writt en guidelines are provided and easy reachable and must be used.
Abstract (croatian)
Provedba imunoterapije u mnogim vrstama karcinoma postigla je pozitivne rezultate u kontroli i liječenju tumora. Koncept imunoterapije razlikuje se u usporedbi s konvencionalnim terapijama tumora. Dok su kemoterapija, hormonska ili biološka terapija svojim djelovanjem usmjerena na uništenje tumorske stanice i mehanizama u tumoru, imunoterapija cilja imunološki sustav domaćina. Pri tome se jačaju obrambeni procesi i reakcije ili se korištenjem imunoterapije dovodi do deblokiranja procesa kontrole imunoloških reakcija. Osim pozitivnih rezultata u kontroli tumora, povećanje imunogenosti može izazvati štetu drugim tkivima i sustavima u obliku nuspojava ili neželjenih nuspojava terapije. Rano prepoznavanje nuspojava od presudne je važnosti, a pravodobno zbrinjavanje može smanjiti oštećenje i težinu popratne pojave. Znanje o mogućim nuspojavama je nužno osigurati kroz dobro i sveobuhvatno obrazovanje svih medicinskih djelatnika uključenih u liječenje, a jednako je tako važno podučiti i s popratnim pojavama upoznati i pacijenata prije liječenja. Pisane smjernice pružene su i lako dostupne i moraju se koristiti.
Keywords (english)
Keywords (croatian)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleLibri Oncologici : Croatian Journal of Oncology
Numberingvol. 45, no. 2-3, pp. 78-80
p-ISSN0300-8142
e-ISSN2584-3826
URN:NBNurn:nbn:hr:184:134188
Publication2017-12-21
Document URLhttp://hrcak.srce.hr/192224
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2018-01-10 18:45:24